Implementing treatment strategies for different types of depression
- PMID: 26829432
- DOI: 10.4088/JCP.14077su1c.02
Implementing treatment strategies for different types of depression
Abstract
Diagnosing and treating major depressive disorder (MDD) accurately and efficiently is challenging for many clinicians. Recent additions to the Diagnostic and Statistical Manual of Mental Disorders (DSM) as well as potential moderators of antidepressant response such as pretreatment phenomenological characteristics (eg, body mass index, drug metabolism markers) may help physicians to better stratify patients and make informed decisions on the best course of treatment to obtain remission. The evidence base suggests that combining traditional antidepressant therapy with atypical antipsychotics may increase the chance for remission. Other strategies that may help include switching to another antidepressant as monotherapy or combining lithium, thyroid hormone, or psychotherapy. Moreover, in some cases, a manualized-based psychotherapeutic approach may be an appropriate first-line or alternative treatment avenue for adults with MDD.
© Copyright 2016 Physicians Postgraduate Press, Inc.
Similar articles
-
When should you move beyond first-line therapy for depression?J Clin Psychiatry. 2010;71 Suppl 1:16-20. doi: 10.4088/JCP.9104su1c.03. J Clin Psychiatry. 2010. PMID: 20977871
-
Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.Annu Rev Psychol. 2014;65:267-300. doi: 10.1146/annurev.psych.121208.131653. Epub 2013 Sep 13. Annu Rev Psychol. 2014. PMID: 24405361 Review.
-
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.J Affect Disord. 2009 Oct;117 Suppl 1:S15-25. doi: 10.1016/j.jad.2009.06.042. Epub 2009 Aug 13. J Affect Disord. 2009. PMID: 19682749
-
[Residual symptoms and recurrence in major depressive disorder].Encephale. 2010 Dec;36 Suppl 5:S108-11. doi: 10.1016/S0013-7006(10)70040-3. Encephale. 2010. PMID: 21211628 Review. French.
-
Treatment-resistant depression: prevalence, risk factors, and treatment strategies.J Clin Psychiatry. 2011 May;72(5):e18. doi: 10.4088/JCP.8133tx4c. J Clin Psychiatry. 2011. PMID: 21658343
Cited by
-
Depressive disorders: Treatment failures and poor prognosis over the last 50 years.Pharmacol Res Perspect. 2019 May 3;7(3):e00472. doi: 10.1002/prp2.472. eCollection 2019 Jun. Pharmacol Res Perspect. 2019. PMID: 31065377 Free PMC article. Review.
-
Multiple examinations indicated associations between abnormal regional homogeneity and cognitive dysfunction in major depressive disorder.Front Psychol. 2023 Jan 26;13:1090181. doi: 10.3389/fpsyg.2022.1090181. eCollection 2022. Front Psychol. 2023. PMID: 36778176 Free PMC article.
-
New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.Cell Death Discov. 2024 May 1;10(1):205. doi: 10.1038/s41420-024-01974-9. Cell Death Discov. 2024. PMID: 38693106 Free PMC article. Review.
-
Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study.BMC Psychiatry. 2023 Nov 13;23(1):830. doi: 10.1186/s12888-023-05354-y. BMC Psychiatry. 2023. PMID: 37957650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical